Description

PNC27 represents a synthetic peptide designed to investigate p53-mediated anticancer mechanisms and selective targeting of cancer cells in research applications. The compound incorporates a membrane-penetrating sequence linked to a p53-derived peptide designed to interact with cellular targets involved in cancer cell regulation. PNC27 has been studied for its ability to selectively affect cancer cells while demonstrating reduced activity against normal cells, making it valuable for investigating targeted cancer research approaches. The peptide functions through mechanisms that may involve p53 pathway activation, membrane disruption in cancer cells, and modulation of cellular survival pathways. Research applications include investigation of cancer biology, p53 signaling mechanisms, selective cancer cell targeting strategies, and the development of peptide-based approaches for cancer research. For research use only.